Monthly pulsed high‐dose dexamethasone vs prednisolone
≥ 1 point improvement on INCAT disability score at 12 months · patients with chronic inflammatory demyelinating polyradiculoneuropathy
Monthly pulsed high‐dose dexamethasone may leads to higher ≥ 1 point improvement on INCAT disability score at 12 months compared with oral prednisolone (low certainty).
1 finding from 1 review
- Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy 2017 · Cochrane Headline outcomes onlyRR 1.241 study · 40 participantsLow